Sclerotherapy for hydroceles.
Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.
Rencken
R K
RK
Department of Urology, Medical University of Southern Africa, Pretoria.
Bornman
M S
MS
Reif
S
S
Olivier
I
I
D000553:Ambulatory Care; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012008:Recurrence; D012382:Rolitetracycline / Q000008:administration & dosage; D015911:Sclerotherapy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D012981:Sodium Tetradecyl Sulfate / Q000008:administration & dosage; D006848:Testicular Hydrocele / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*
D012382:Rolitetracycline; D012981:Sodium Tetradecyl Sulfate